Chronic Hepatitis

Top Story

Harvoni joins growing DAA options for younger patients with HCV

July 17, 2019
Feature

Telemedicine takes focus in study of HCV treatment in methadone centers

July 17, 2019
With $7 million from the Patient-Centered Outcomes Research Institute, seven opioid treatment programs announced entry into an ongoing study of telemedicine for…

HCV micro-elimination program seeks to cure high-risk Kentucky county

July 11, 2019
Intent Solutions announced a partnership with the University of Kentucky in a $15 million federal grant program aimed at eliminating hepatitis C in an eastern Kentucky…
In the Journals

VCTE superior marker for measuring fibrosis in patients with HBV/HIV

July 10, 2019
Vibration-controlled transient elastography outperformed aspartate aminotransferase to platelet ratio index and Fibrosis-4 index as a noninvasive biomarker for advanced…
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Opioid use more common in chronic liver disease than other chronic diseases

November 21, 2018
More »